 |
|
Ipodate Therapy in Patients With Severe Destruction-Induced Thyrotoxicosis
Ridha Arem, MD;
Bala Munipalli, MD
Arch Intern Med. 1996;156(15):1752-1757.
Abstract
We describe 4 patients with severe destruction-induced thyrotoxicosis who had a rapid clinical response to oral sodium ipodate (500 mg daily). The underlying thyroid disorders in the patients were postpartum thyroiditis, subacute thyroiditis, silent thyroiditis, and radiation-induced thyroiditis. Ipodate therapy was given for 6 to 10 weeks until restoration of thyroid function to normal. In all patients, an almost complete resolution of symptoms occurred by the third day of ipodate treatment. In the patient with radiation thyroiditis, a daily clinical score of thyrotoxicosis declined within 2 to 3 days. The score remained low as long as the patient was receiving ipodate, but 2 attempts to discontinue ipodate therapy while thyroxine levels were elevated resulted in a rise of the thyrotoxicosis clinical score. This suggests that ipodate therapy, by rapidly reducing triiodothyronine levels through inhibition of the 5' monodeiodination and blockage of the peripheral effects of thyroid hormone, controls severe thyrotoxicosis mediated by destruction and should be considered in this setting in conjunction with β-adrenergic blockade.
Arch Intern Med. 1996;156:1752-1757
Author Affiliations
From the Department of Medicine, Baylor College of Medicine, Houston, Tex.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Treatment of Hyperthyroidism Associated with Thyrotropin-Secreting Pituitary Adenomas with Iopanoic Acid
Dhillon et al.
J. Clin. Endocrinol. Metab. 2004;89:708-711.
ABSTRACT
| FULL TEXT
Treatment of Type II Amiodarone-Induced Thyrotoxicosis by Either Iopanoic Acid or Glucocorticoids: A Prospective, Randomized Study
Bogazzi et al.
J. Clin. Endocrinol. Metab. 2003;88:1999-2002.
ABSTRACT
| FULL TEXT
|
